Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diprobase Cream and Doublebase Gel are topical emollient formulations used to manage dry skin conditions and restore the skin's natural barrier. Diprobase Cream is a paraffin-based emollient containing white soft paraffin and liquid paraffin, while Doublebase Gel is a moisturizing gel containing liquid paraffin and isopropyl myristate. These products were evaluated as the intervention arm in the Barrier Enhancement for Eczema Prevention (BEEP) trial (ISRCTN21528841), which investigated whether daily emollient application during the first year of life could prevent the development of atopic eczema in high-risk infants. The trial concluded that the intervention did not significantly reduce eczema incidence at two years and was associated with an increased risk of skin infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Diprobase Cream + Doublebase Gel.